Specify a stock or a cryptocurrency in the search bar to get a summary
Lupin Limited
LUPINLupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India and internationally. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, gynecology and women's health, central nervous system, oncology, immunology, genomics, metabolic disorders, dermatology, urology, pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies, as well as engages in the bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India. Address: Kalpataru Inspire, Mumbai, India, 400055
Analytics
WallStreet Target Price
168 276.42 INRP/E ratio
36.6272Dividend Yield
0.39 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures LUPIN
Dividend Analytics LUPIN
Dividend growth over 5 years
-20 %Continuous growth
1 yearPayout Ratio 5 years average
-2 %Dividend History LUPIN
Stock Valuation LUPIN
Financials LUPIN
Results | 2019 | Dynamics |